Abstract
In his influential book “The Structure of Scientific Revolutions” published in 1962, Thomas Kuhn argued that researchers in every field of scientific enquiry are always guided by theoretical assumptions, presuppositions, and hypotheses that constitute the prevailing scientific paradigm under which they operate at any given time (Kuhn 1962). When they operate within a shared paradigm, a scientific community working in a particular field will be committed to using certain strategies and experimental approaches that are accepted as being essential for trying to solve the problem at hand.
Frontiers in Immunology, 2015, 6, 326.
Marc H V Van Regenmortel
Copyright: © 2015 Van Regenmortel
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/legalcode)
To view the original article, visit https://www.frontiersin.org/articles/10.3389/fimmu.2015.00326/full
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dimitrov DS. Therapeutic antibodies, vaccines and antibodyomes. MAbs. 2010;2:347–56.
Dimitrov JD, Planchais C, Kang J, Pashov A, Vassilev TL, Kaveri SV, Lacroix-Desmazes S. Heterogeneous antigen recognition behavior of induced polyspecific antibodies. Biochem Biophys Res Commun. 2010;398:266–71.
Douek DC, Kwong PD, Nabel GJ. The rational design of an AIDS vaccine. Cell. 2006;124:677–81.
Eisen HN, Chakraborty AK. Evolving concepts of specificity in immune reactions. Proc Natl Acad Sci U S A. 2010;107:22373–80. https://doi.org/10.1073/pnas.1012051108.
Esparza J. What has 30 years of HIV research taught us? Vaccine. 2013b;1:513–26.
Karlsson-Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol. 2008;6:143–55. https://doi.org/10.1038/nrmicro1819.
Kuhn TS. The structure of scientific revolutions. Chicago, IL: University of Chicago Press; 1962. p. 1–264.
Nabel GJ, Kwong PD, Mascola JR. Progress in the rational design of an AIDS vaccine. Philos Trans R Soc Lond B Biol Sci. 2011;366:2759–65.
Notkins AL. Polyreactivity of antibody molecules. Trends Immunol. 2004;25:174–9.
Prabakaran P, Chen W, Dimitrov DS. The antibody germline/maturation hypothesis, elicitation of broadly neutralizing antibodies against HIV-1 and cord blood IgM repertoires. Front Immunol. 2014;5:398.
Sperling R, Francus T, Siskind GW. Degeneracy of antibody specificity. J Immunol. 1983;131:882–5.
Van Regenmortel MHV. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J Mol Recognit. 2006;19:183–7.
Van Regenmortel MHV. The rational design of biological complexity: a deceptive metaphor. Proteomics. 2007;7:965–75.
Van Regenmortel MHV. Limitations to the structure-based design of HIV-1 vaccine immunogens. J Mol Recognit. 2011b;24:741–53.
Van Regenmortel MHV. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine. Arch Virol. 2012a;157:1–20.
Van Regenmortel MHV. Basic research in HIV vaccinology is hampered by reductionist thinking. Front Immunol. 2012b;3:194. https://doi.org/10.3389/fimmu.2012.00194.
Van Regenmortel MHV. Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition. J Mol Recognit. 2014a;27:627–39.
Van Regenmortel MHV. An outdated notion of antibody specificity is one of the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from developing an effective HIV-1 vaccine. Front Immunol. 2014b;5:593. https://doi.org/10.3389/fimmu.1014.00593.
Van Regenmortel MHV. Why does the molecular structure of broadly neutralizing monoclonal antibodies isolated from individuals infected with HIV-1 not inform the rational design of an HIV-1 vaccine? AIMS Public Health. 2015a;2:183–93.
Van Regenmortel MHV, Andrieu JM, Dimitrov DS, Ensoli B, Hioe CE, Moog C, Ruprecht RM. Paradigm changes and the future of HIV vaccine research: a summary of a workshop held in Baltimore on 20 November 2013. J AIDS Clin Res. 2014;5:281. https://doi.org/10.4172/2155–6113.1000281.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Van Regenmortel, M.H.V. (2019). Editorial: Paradigm Changes Are Required in HIV Vaccine Research. In: HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design. Springer, Cham. https://doi.org/10.1007/978-3-030-32459-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-32459-9_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-32458-2
Online ISBN: 978-3-030-32459-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)